rs118204052
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001378615.1(CC2D2A):c.4582C>T(p.Arg1528Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000298 in 1,612,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1528H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001378615.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CC2D2A | NM_001378615.1 | c.4582C>T | p.Arg1528Cys | missense_variant | 36/37 | ENST00000424120.6 | |
CC2D2A | NM_001080522.2 | c.4582C>T | p.Arg1528Cys | missense_variant | 37/38 | ||
CC2D2A | NM_001378617.1 | c.4435C>T | p.Arg1479Cys | missense_variant | 34/35 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CC2D2A | ENST00000424120.6 | c.4582C>T | p.Arg1528Cys | missense_variant | 36/37 | 5 | NM_001378615.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248638Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134870
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1460766Hom.: 0 Cov.: 30 AF XY: 0.0000289 AC XY: 21AN XY: 726654
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74290
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2018 | A likely pathogenic variant has been identified in the CC2D2A gene. The R1528C variant has been reported previously in trans with the c.3774dupT variant in an individual with JSRD (Bachmann-Gagescu et al., 2015). Additionally, R1528C has been observed in trans with other CC2D2A variants (c.3289delG; c.3772-1G>T) and in the homozygous state in association with COACH syndrome and JSRD (Bachmann-Gagescu et al., 2015; Gorden et al., 2008). Different missense variants at the same codon (R1528H) and in a nearby residue (T1526N) have also been reported in the Human Gene Mutation Database in association with Joubert syndrome (Ben-Salem et al., 2014; Stenson et al., 2014). The R1528C variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species; however, the R1528C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, the R1528C variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 14, 2022 | - - |
Joubert syndrome 9 Pathogenic:2
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2010 | - - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 29, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1528 of the CC2D2A protein (p.Arg1528Cys). This variant is present in population databases (rs118204052, gnomAD 0.003%). This missense change has been observed in individual(s) with CC2D2A-related conditions (PMID: 18950740). ClinVar contains an entry for this variant (Variation ID: 744). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CC2D2A protein function with a positive predictive value of 95%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
COACH syndrome 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2010 | - - |
Meckel syndrome, type 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 15, 2023 | Variant summary: CC2D2A c.4582C>T (p.Arg1528Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 248638 control chromosomes. c.4582C>T has been reported in the literature as a homozygous or compound heterozygous genotype in multiple individuals affected with features of Ciliopathies such as Joubert Syndrome/Meckel Syndrome (example, Bachmann-Gagescu_2015, Gorden_2008). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26092869, 18950740). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
CC2D2A-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 04, 2023 | The CC2D2A c.4582C>T variant is predicted to result in the amino acid substitution p.Arg1528Cys. This variant has been reported in the compound heterozygous state in at least two unrelated individuals with Joubert syndrome (Gorden et al 2008. PubMed ID: 18950740; Bachmann-Gagescu R et al 2015. PubMed ID: 26092869). This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-15601237-C-T). Different missense variants affecting the same amino acid (p. Arg1528His and p. Arg1528Cys) have been reported as causative for Joubert syndrome or related disorders (Ben-Salem. 2014. PubMed ID: 27081510; Gorden. 2008. PubMed ID: 18950740). Taken together, the c.4582C>T (p.Arg1528Cys) variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at